Health
Results: 505-516 of 8097

ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer

LifeArc and Global Alzheimer's Platform Foundation - Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer's disease before symptoms begin

Henlius Showcases "Globalisation 2.0" Strategy and Mid-to-Long-Term Innovation Blueprint at JPM 2026

Sobi Receives European Commission Approval for Aspaveli® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN

Doceree Sets the Global Standard for Healthcare Marketing, Building the World's Largest Network of Specialist Medical Publishers

